SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011136
Filing Date
2018-05-07
Accepted
2018-05-07 09:19:34
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krys-10q_20180331.htm 10-Q 911716
2 EX-31.1 krys-ex311_84.htm EX-31.1 23523
3 EX-31.2 krys-ex312_83.htm EX-31.2 24124
4 EX-32.1 krys-ex321_85.htm EX-32.1 24320
  Complete submission text file 0001564590-18-011136.txt   4240489

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krys-20180331.xml EX-101.INS 961543
6 XBRL TAXONOMY EXTENSION SCHEMA krys-20180331.xsd EX-101.SCH 35890
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krys-20180331_cal.xml EX-101.CAL 27749
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krys-20180331_def.xml EX-101.DEF 91799
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20180331_lab.xml EX-101.LAB 262580
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20180331_pre.xml EX-101.PRE 206144
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 18809851
SIC: 2836 Biological Products, (No Diagnostic Substances)